Bavarian Nordic To Supply Vaccine As Monkeypox Appears In UK & Portugal

The monkeypox cases reported this month are evidence of chains of transmission of the virus, according to the European Centre for Disease Prevention and Control, which says that vaccination of high-risk close contacts should be considered after a benefit-risk assessment.

Top view image of pen and stethoscope with Monkeypox wording. Medical concept
Monkeypox is making another appearance in Europe • Source: Shutterstock

Bavarian Nordic A/S has agreed a contract with an “undisclosed” European country for the supply of its smallpox vaccine, Imvanex, after a growing number of cases of monkeypox were confirmed in the UK and Portugal.

The non-replicating vaccine has been approved for both smallpox and monkeypox in the US and Canada, while in Europe it is authorized only for smallpox “but has previously been provided for

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe